Where a client has approved it, we name them. What we did for each stays confidential, so what follows describes method rather than specific engagements. Named references will take your call.
In short
Hibridge has delivered marketing, launch, conference and commercial analytics programmes for pharmaceutical companies working in Egypt and the MENA region, including global manufacturers. Clients who have approved disclosure in writing are named. Case detail is published only where a client has approved that too.
Case studies in preparation. The structure below is final; the content is placeholder pending client approval.
Cardiovascular
Launch sequencing for a cardiovascular brand entering the Egyptian market
A top-5 global pharmaceutical company
The problem
PLACEHOLDER: the commercial problem in two sentences.
What we did
PLACEHOLDER: what was done, in three to four sentences.
Result
PLACEHOLDER: the measurable result, with the measurement period stated.